Tradestie Institutional Equity Comparison Engine

EIKN vs EVMN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EVMN Overall Edge

EVMN Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evommune, Inc. (EVMN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EIKN trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus EVMN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EIKN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EVMN sits in SURGE (53rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EIKN N/M vs EVMN N/M Fwd P/E
Growth & Margin Winner EVMN
Op Margin N/A vs 0.0% ยท YoY N/A vs +0.0%
Momentum & Technical Winner EVMN
1Y -64.1% vs -61.0% ยท 52W Pos 3% vs 8%
Options & Structure Winner EVMN
UNCLASSIFIED (N/A IV) vs SURGE (53rd %ile IV)
EIKN US Equity
EIKN
Institutional Equity
$5.38
-9.95% 1D
Market Cap N/A
1M Return -27.43%
1Y Return -64.1%
Forward P/E N/M
Unified AI Score
43.2 / 100 HOLD
Tech 45.0 Fund 48.0 Flow 50.0 Mom 50.0
EVMN US Equity
Evommune, Inc.
Pharmaceutical Preparations
$7.10
-6.95% 1D
Market Cap $315.5M
1M Return +37.33%
1Y Return -61.03%
Forward P/E N/M
Unified AI Score
30.0 / 100 SELL
Tech 50.0 Fund 35.0 Flow 69.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EIKN -64.1% EVMN -61.03% Spread: +6.72 pp (EVMN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EIKN TTM Op. Margin: N/A EVMN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EIKN vs EVMN. Trailing 12-month operating profitability (EIKN N/A vs EVMN 0.0%) and valuation multiples (EIKN N/M vs EVMN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EIKN (1) vs EVMN (7)
Institutional Metric EIKN EVMN Criterion Row Winner
Market Capitalization Scale N/A $315.5M Larger Scale EVMN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A +0.0% Higher Growth EVMN
Operating Margin (TTM) Profitability N/A 0.0% Higher Margin EVMN
Net Profit Margin Profitability N/A 0.0% Higher Margin EVMN
Return on Equity (ROE) Capital Efficiency N/A -69.5% Higher ROE EVMN
52-Week Range Position Momentum 3% ($5โ€“$17) 8% ($5โ€“$33) Stronger Trend EVMN
Beta / 30D Volatility Risk Regime 2.05ฮฒ ยท 133% Vol 1.05ฮฒ ยท 118% Vol Lower Realized Risk EVMN
Unified Institutional Score Composite Signal 43.2 / 100 (HOLD) 30.0 / 100 (SELL) Higher Composite EIKN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EIKN vs EVMN Buy Guide
EIKN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EIKN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EVMN SURGE
5d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EVMN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EIKN nor EVMN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.